The Suppression of Adjuvant-induced Inflammation and the Inhibition of the Serum and Tissue IL-17, TNF-α and IL-1β levels by Thymol and Carvacrol

Nasser Gholijani, Zahra Amirghofran*

Abstract


Background and Aim: Thymol and carvacrol are two important components of thyme that have multiple medicinal uses. This study investigates the in vivo effects of these natural products on adjuvant-induced inflammation and secretion of interleukin (IL)-17 and key inflammatory cytokines in rats.

Materials and Methods: We injected complete Freund’s adjuvant (CFA) into the hind paws of rats in order to induce inflammation. Each of the CFA-treated rat groups received gavages of thymol, carvacrol, or vehicle (CFA-only group). Rats’ paws and ankle edema were measured and then we were able to determine an inflammatory score based on the results. After 72 h of inflammation induction, sera were collected and subsequently inflamed tissue extracts were prepared for cytokine assay by ELISA.

Results: Both components significantly decreased paw edema in rats (p<0.01). Thymol decreased ankle edema to 61.6% of edema in CFA-only rats (p<0.001). We observed a decreased inflammatory score in the thymol and carvacrol-treated rats. The evaluation of the tissue and serum inflammatory cytokine levels showed that both components decreased tumor necrosis factor (TNF)-α levels (p<0.05). Thymol and carvacrol reduced interleukin (IL)-1β serum and tissue levels, respectively. These components reduced tissue levels of IL-17 from 148.4±13.4pg/ml in CFA-only rats to 90.1±18.9pg/ml (thymol) and 82.3±9.2pg/ml (carvacrol). Both components decreased serum IL-17 levels in rats (p<0.05). In comparison, the anti-inflammatory drug, indomethacin, reduced the inflammatory score and decreased tissue TNF-α and IL-1β levels but did not affect IL-17 production.

Conclusion: Carvacrol and thymol could relieve inflammation symptoms possibly by downregulating serum and tissue IL-17 expression in addition to key pro-inflammatory cytokines, TNFα and IL-1β.


Keywords


Thymol, carvacrol, anti-inflammatory, adjuvant-induced inflammation

Full Text:

PDF

References


Cavaillon J-M. Pro-versus anti-inflammatory cytokines: Myth or reality. Cell Moll Biol 2001;47(4):695-702.

Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117(4):1162-72.

Saperstein S, Chen L, Oakes D, Pryhuber G, Finkelstein J. IL-1β augments TNF-α–mediated inflammatory responses from lung epithelial cells.J Interferon Cytokine Res 2009;29(5):273-84.

Dinarello CA. Anti-inflammatory agents: Present and future. Cell 2010;140(6):935-50.

Witowski J, Książek K, Jörres A. Interleukin-17: A mediator of inflammatory responses. Cell Mol Life Sci 2004;61(5):567-79.

Miossec P, Kolls JK. Targeting IL-17 and Th17 cells in chronic inflammation. Nat Rev Drug Discov 2012;11(10):763-76.

de Cássia da Silveira E Sá R, Andrade LN, Dos Reis Barreto de Oliveira R, de Sousa DP. A review on anti-inflammatory activity of phenylpropanoids found in essential oils. Molecules 2014;19(2):1459-80.

Gholijani N, Gharagozloo M, Farjadian S, Amirghofran Z. Modulatory effects of thymol and carvacrol on inflammatory transcription factors in lipopolysaccharide-treated macrophages. J. Immunotoxicol 2016;13(2):157-64.

Amirghofran Z, Ahmadi H, Karimi MH, Kalantar F, Gholijani N, Malek-Hosseini Z. In vitro inhibitory effects of thymol and carvacrol on dendritic cell activation and function. Pharm Biol 2015:1-8.

Gholijani N, Gharagozloo M, Kalantar F, Ramezani A, Amirghofran Z. Modulation of cytokine production and transcription factors activities in human jurkat t cells by thymol and carvacrol. Adv Pharm Bull 2015;5(Suppl 1):653-60.

Gholijani N, Amirghofran Z. Effects of thymol and carvacrol on T-helper cell subset cytokines and their main transcription factors in ovalbumin-immunized mice. J. Immunotoxicol 2016 Sep;13(5):729-37.

Ribeiro AR, Diniz PB, Pinheiro MS, Albuquerque-Júnior RL, Thomazzi SM. Gastroprotective effects of thymol on acute and chronic ulcers in rats: The role of prostaglandins, ATP-sensitive K(+) channels, and gastric mucus secretion.Chem Biol Interact 2016;244:121-8.

Da Silva Lima M, Quintans-Júnior L.J, de Santana W.A, Kaneto C.M, Soares M.B.P and Villarreal C.F.Anti-inflammatory effects of carvacrol: Evidence for a key role of interleukin-10. Eur J Pharmacol 2012;699(1):112-17.

Nezić L, Skrbić R, Dobrić S, Stojiljković MP, Jaćević V, Satara SS, et al. Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation. Basic Clin Pharmacol Toxicol. 2009;104(3):185-91.

Landa P, Kokoska L, Pribylova M, Vanek T, Marsik P. In vitro anti-inflammatory activity of carvacrol: Inhibitory effect on cox-2 catalyzed prostaglandin E2 biosynthesisb. Arch. Pharmacal Res 2009;32(1):75-8.

Liang D, Li F, Fu Y, Cao Y, Song X, Wang T, et al. Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κb and mapk signaling pathways in mouse mammary epithelial cells. Inflammation 2014;37(1):214-22.

Zhou E, Fu Y, Wei Z, Yu Y, Zhang X, Yang Z. Thymol attenuates allergic airway inflammation in ovalbumin (OVA)-induced mouse asthma. Fitoterapia 2014; 96:131-7.

Riella KR, Marinho RR, Santos JS, Pereira-Filho RN, Cardoso JC, Albuquerque-Junior RL, Thomazzi SM. Anti-inflammatory and cicatrizing activities of thymol, a monoterpene of the essential oil from Lippia gracilis, in rodents. J Ethnopharmacol 2012; 28;143(2):656-63.

Arigesavan K, Sudhandiran G. Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats. Biochem Biophys Res Commun 2015; 29; 461(2) :314-20.

Bakır M, Geyikoglu F, Colak S, Turkez H, Bakır TO, Hosseinigouzdagani M. The carvacrol ameliorates acute pancreatitis-induced liver injury via antioxidant response. Cytotechnology 2015; 8.

Feng X, Jia A. Protective effect of carvacrol on acute lung injury induced by.

lipopolysaccharide in mice. Inflammation 2014;37(4):1091-101.

Guimarães AG, Xavier MA, de Santana MT, Camargo EA, Santos CA, Brito FA, et al. Carvacrol attenuates mechanical hypernociception and inflammatory response.Naunyn Schmiedebergs Arch Pharmacol 2012;385(3):253-63.

Damasceno SR, Oliveira FRA, Carvalho NS, Brito CF, Silva IS, Sousa FBM, et al. Carvacryl acetate, a derivative of carvacrol, reduces nociceptive and inflammatory response in mice. Life Sci 2014;94(1):58-66.

Nagoor Meeran MF, Jagadeesh GS, Selvaraj P. Thymol attenuates inflammation in

isoproterenol induced myocardial infarcted rats by inhibiting the release of lysosomal enzymes and downregulating the expressions of proinflammatory cytokines. Eur J Pharmacol 2015; 5;754: 153-61.

Gabr MA, Jing L, Helbling AR, Sinclair SM, Allen KD, Shamji MF, et al. Interleukin-17 synergizes with IFNγ or TNFα to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J Orthop Res 2011;29(1):1-7.

Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010;129(3):311-21.

Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116(5): 1218-22.

Toussirot É. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases. Inflamm Allergy Drug Targets 2012;11(2):159-68.




DOI: https://doi.org/10.22087/hmj.v0i0.613

Refbacks

  • There are currently no refbacks.


This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

                               

This work is licensed under a Creative Commons license (CC-BY).  However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.


 

Lorestan University of Medical Sciences, Khorramabad, Iran.

ISSN: 2538-2144